JP2024534427A5 - - Google Patents
Info
- Publication number
- JP2024534427A5 JP2024534427A5 JP2024516849A JP2024516849A JP2024534427A5 JP 2024534427 A5 JP2024534427 A5 JP 2024534427A5 JP 2024516849 A JP2024516849 A JP 2024516849A JP 2024516849 A JP2024516849 A JP 2024516849A JP 2024534427 A5 JP2024534427 A5 JP 2024534427A5
- Authority
- JP
- Japan
- Prior art keywords
- milbexian
- use according
- pharmaceutically acceptable
- acceptable salt
- daily dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163245522P | 2021-09-17 | 2021-09-17 | |
| US63/245,522 | 2021-09-17 | ||
| US202163278582P | 2021-11-12 | 2021-11-12 | |
| US63/278,582 | 2021-11-12 | ||
| PCT/US2022/043797 WO2023043999A1 (en) | 2021-09-17 | 2022-09-16 | Milvexian for prevention and treatment of thromboembolic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534427A JP2024534427A (ja) | 2024-09-20 |
| JP2024534427A5 true JP2024534427A5 (https=) | 2025-09-25 |
Family
ID=83688923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516849A Pending JP2024534427A (ja) | 2021-09-17 | 2022-09-16 | 血栓塞栓性障害を予防かつ治療するためのミルベキシアン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250099466A1 (https=) |
| EP (1) | EP4401736A1 (https=) |
| JP (1) | JP2024534427A (https=) |
| KR (1) | KR20240060820A (https=) |
| AU (1) | AU2022345862A1 (https=) |
| CA (1) | CA3232633A1 (https=) |
| CL (1) | CL2024000776A1 (https=) |
| IL (1) | IL310894A (https=) |
| MX (1) | MX2024002857A (https=) |
| TW (1) | TW202327607A (https=) |
| WO (1) | WO2023043999A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA71692A (fr) * | 2022-08-01 | 2025-05-30 | Bristol-Myers Squibb Company | Utilisation de milvexian pour le traitement ou la prévention d'un accident vasculaire cérébral ischémique |
| TW202506125A (zh) * | 2023-04-19 | 2025-02-16 | 美商必治妥美雅史谷比公司 | 米爾維仙(milvexian)於治療及預防患有心血管或腦血管疾病之患者之血栓病況的用途 |
| WO2024220803A1 (en) * | 2023-04-19 | 2024-10-24 | Bristol-Myers Squibb Company | Use of milvexian in the treatment and prevention of thrombotic conditions in patients with atrial fibrilation |
| EP4698172A1 (en) * | 2023-04-19 | 2026-02-25 | Bristol-Myers Squibb Company | Use of milvexian for treating or preventing adverse cerebrovascular events or adverse cardiovascular events in patients having acute coronary syndrome |
| WO2025126240A1 (en) * | 2023-12-12 | 2025-06-19 | Dr. Reddy's Laboratories Limited | Pharmaceutical compositions and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9453018B2 (en) * | 2014-10-01 | 2016-09-27 | Bristol-Myers Squibb Company | Pyrimidinones as factor XIa inhibitors |
| BR112021020257A2 (pt) | 2019-04-11 | 2021-12-07 | Bristol Myers Squibb Co | Desempenho intensificado de sólido amorfo e formulações solubilizadas para realizar concentrações de plasma terapêutico |
-
2022
- 2022-09-16 IL IL310894A patent/IL310894A/en unknown
- 2022-09-16 US US18/692,560 patent/US20250099466A1/en active Pending
- 2022-09-16 JP JP2024516849A patent/JP2024534427A/ja active Pending
- 2022-09-16 KR KR1020247012366A patent/KR20240060820A/ko active Pending
- 2022-09-16 TW TW111135090A patent/TW202327607A/zh unknown
- 2022-09-16 CA CA3232633A patent/CA3232633A1/en active Pending
- 2022-09-16 AU AU2022345862A patent/AU2022345862A1/en active Pending
- 2022-09-16 WO PCT/US2022/043797 patent/WO2023043999A1/en not_active Ceased
- 2022-09-16 EP EP22786640.7A patent/EP4401736A1/en active Pending
- 2022-09-16 MX MX2024002857A patent/MX2024002857A/es unknown
-
2024
- 2024-03-15 CL CL2024000776A patent/CL2024000776A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024534427A5 (https=) | ||
| IL310894A (en) | Milovacian for the prevention and treatment of thromboembolic disorders | |
| AU2018357775B2 (en) | New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD) | |
| CN107519159A (zh) | 复方组合物 | |
| JP2023535744A5 (https=) | ||
| JP2017510607A5 (https=) | ||
| JP2023552700A5 (https=) | ||
| JP2022550919A5 (https=) | ||
| JP2023526754A5 (https=) | ||
| JP2021532171A5 (https=) | ||
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2016505050A5 (https=) | ||
| HRP20251043T1 (hr) | Novi oralni farmaceutski pripravak i režim doziranja za terapiju progresivnih fibrozirajućih intersticijskih bolesti pluća | |
| JP2024540439A5 (https=) | ||
| JP2024520690A5 (https=) | ||
| JP2010106019A (ja) | リマプロストを含有してなる癌化学療法に起因する末梢神経障害予防、治療および／または症状軽減剤 | |
| MX2022012693A (es) | Composicion que comprende metilfolato. | |
| US9545419B1 (en) | Method and compositions for treating chronic inflammatory disorders | |
| JP2024527175A5 (https=) | ||
| US20110117070A1 (en) | Compositions and methods for treating headache | |
| CN108472375A (zh) | 中重度流感的治疗方法 | |
| JP2022504435A5 (https=) | ||
| JP2017511307A5 (https=) | ||
| IL319025A (en) | Methods for treating or preventing endometriosis | |
| JP2014530249A5 (https=) |